Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
6.81B
Market cap6.81B
Price-Earnings ratio
42.36
Price-Earnings ratio42.36
Dividend yield
Dividend yield
Average volume
464.57K
Average volume464.57K
High today
$258.81
High today$258.81
Low today
$251.35
Low today$251.35
Open price
$255.09
Open price$255.09
Volume
168.22K
Volume168.22K
52 Week high
$343.12
52 Week high$343.12
52 Week low
$211.43
52 Week low$211.43

Stock Snapshot

Bio-Rad Laboratories Class A(BIO) stock is priced at $254.32, giving the company a market capitalization of 6.81B. It carries a P/E multiple of 42.36.

During the trading session on 2026-05-09, Bio-Rad Laboratories Class A(BIO) shares reached a daily high of $258.81 and a low of $251.35. At a current price of $254.32, the stock is +1.2% higher than the low and still -1.7% under the high.

Trading activity shows a volume of 168.22K, compared to an average daily volume of 464.57K.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $343.12 and a low of $211.43.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $343.12 and a low of $211.43.

BIO News

The Motley Fool 5d
Bio-Rad Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. Thursday, July 31, 2025 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Norman D. Schwartz President and Chief Operatin...

Bio-Rad Q2 2025 Earnings Call Transcript

Analyst ratings

67%

of 6 ratings
Buy
16.7%
Hold
66.7%
Sell
16.7%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.